Author

T. Chardes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Mallavialle· 2 shared L. B. Alcaraz· 2 shared P. Roger· 2 shared S. Guiu· 2 shared W. Jacot· 2 shared A. Musnier· 1 shared A. Pelegrin· 1 shared A. Turtoi· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Mallavialle

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity

L. B. Alcaraz, A. Mallavialle, C. Mollevi, F. Boissiere Michot, H. Mansouri, J. Simony Lafontaine, V. Laurent Matha, T. Chardes, W. Jacot, A. Turtoi, P. Roger, S. Guiu, E. Liaudet Coopman

bioRxiv · Nov 3, 2021Cancer Biology

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment

L. B. Alcaraz, A. Mallavialle, T. David, D. Derocq, F. Delolme, C. Dieryckx, F. Boissiere-Michot, J. Simony-Lafontaine, S. Du Manoir, P. Huesgen, C. M. Overall, S. Tartare-Deckert, W. Jacot, T. Chardes, S. Guiu, , E. Liaudet-Coopman

The paper identifies a 9-kDa SPARC fragment released by cathepsin D in TNBC that promotes tumor progression by enhancing cell migration and invasion.

bioRxiv · Oct 22, 2020 · PreprintCancer Biology

Biasing HER4 Tyrosine Kinase Signaling with Antibodies: Induction of Cell Death by Antibody-Dependent HER4 Intracellular Domain Trafficking

R. Lanotte, V. Garambois, N. Gaborit, C. Larbouret, A. Musnier, P. Martineau, A. Pelegrin, T. Chardes

This paper shows that anti-HER4 antibodies can mimic NRG1's tumor suppressor effects by inducing 4ICD mitochondrial trafficking and cell death in cancer cells.

bioRxiv · Dec 20, 2019Cancer Biology